Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19701 | 26405614 | Cardiovasc Endocrinol | Relevance of low testosterone to non-alcoholic fatty liver disease. | 2015 | Details |
| A19704 | 26404062 | Diabetologia | A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. | 2015 | Details |
| A19706 | 26402655 | Transpl Int | Liver transplantation for nonalcoholic steatohepatitis in young patients. | 2016 | Details |
| A19713 | 26398456 | Eur J Gastroenterol Hepatol | Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus. | 2015 | Details |
| A19719 | 26395746 | Int J Obes (Lond) | A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. | 2015 | Details |
| A19723 | 26394730 | Endocrinol Metab (Seoul) | Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study. | 2015 | Details |
| A19724 | 26394261 | Appl Physiol Nutr Metab | Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats. | 2015 | Details |
| A19727 | 26394161 | J Hepatol | Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. | 2015 | Details |
| A19736 | 26385233 | QJM | Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2015 | Details |
| A19737 | 26383163 | Cancer Res | Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma. | 2015 | Details |
| A19739 | 26381272 | Diabetes Metab Res Rev | Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies. | 2015 | Details |
| A19740 | 26380042 | World J Hepatol | Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how? | 2015 | Details |
| A19751 | 26378642 | Semin Liver Dis | Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD. | 2015 | Details |
| A19752 | 26378641 | Semin Liver Dis | Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander. | 2015 | Details |
| A19759 | 26374819 | Laeknabladid | [Importance of waist circumference measurements when following children with obesity: Serious abnormalities in blood values of Iceandic children with obesity]. | 2015 | Details |
| A19763 | 26367736 | Eur Rev Med Pharmacol Sci | Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. | 2015 | Details |
| A19768 | 26363598 | Curr Diab Rep | Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Obesity-Related Traits. | 2015 | Details |
| A19774 | 26358367 | Sci Rep | Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs. | 2015 | Details |
| A19777 | 26356502 | PLoS One | Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State. | 2015 | Details |
| A19781 | 26355033 | Sci Transl Med | Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. | 2015 | Details |
| A19787 | 26349165 | Trop Gastroenterol | Nonalcoholic Fatty Liver Disease--The Clinician's Perspective. | 2015 | Details |
| A19798 | 26343077 | Med Ultrason | Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A19801 | 26341826 | J Hepatol | Hepatocellular carcinoma and lifestyles. | 2015 | Details |
| A19803 | 26340970 | Eur J Endocrinol | Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease. | 2015 | Details |
| A19806 | 26339423 | Int J Clin Exp Pathol | Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19819 | 26328027 | World J Hepatol | Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. | 2015 | Details |
| A19820 | 26328025 | World J Hepatol | From the stomach to other organs: Helicobacter pylori and the liver. | 2015 | Details |
| A19833 | 26317347 | PLoS One | Suppressive Role of PPARγ-Regulated Endothelial Nitric Oxide Synthase in Adipocyte Lipolysis. | 2015 | Details |
| A19834 | 26316717 | Drug Des Devel Ther | Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. | 2015 | Details |
| A19835 | 26316434 | J Clin Res Pediatr Endocrinol | Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19836 | 26316333 | Sci Rep | GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance. | 2015 | Details |
| A19838 | 26315841 | Int J Obes (Lond) | Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK. | 2015 | Details |
| A19842 | 26314837 | J Gastroenterol | Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. | 2015 | Details |
| A19848 | 26310987 | Int J Cardiol | Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. | 2015 | Details |
| A19849 | 28943619 | Diseases | MOGAT2: A New Therapeutic Target for Metabolic Syndrome. | 2015 | Details |
| A19852 | 26305052 | Biochem Cell Biol | Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol. | 2015 | Details |
| A19859 | 26300958 | Chin Med | Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model. | 2015 | Details |
| A19860 | 26300331 | J Nutr Biochem | Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. | 2015 | Details |
| A19867 | 26297911 | Biochem Pharmacol | A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. | 2015 | Details |
| A19870 | 26293833 | Eur J Intern Med | Increased circulating adiponectin in males with chronic HCV hepatitis. | 2015 | Details |
| A19872 | 26292849 | Br J Pharmacol | Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes. | 2015 | Details |
| A19876 | 26290284 | Front Med | Molecular mechanisms of fatty liver in obesity. | 2015 | Details |
| A19878 | 26289505 | Niger J Clin Pract | Nonalcoholic fatty liver disease: Synopsis of current developments. | 2016 | Details |
| A19892 | 26281176 | Eksp Klin Gastroenterol | [ALLELES C282Y AND H63D HFE GENE, INSULIN RESISTANCE AND SUSCEPTIBILITY TO DISTURBANCE OF PORPHYRIN METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2015 | Details |
| A19893 | 26280342 | FP Essent | Metabolic Syndrome: Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19900 | 26278350 | Diabetes Res Clin Pract | Country of birth modifies the association of fatty liver index with insulin action in Middle Eastern immigrants to Sweden. | 2015 | Details |
| A19905 | 26273621 | Biomed Res Int | Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. | 2015 | Details |
| A19907 | 26273604 | Biomed Res Int | The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19908 | 26273598 | Biomed Res Int | Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis. | 2015 | Details |
| A19913 | 26271188 | Int J Obes (Lond) | Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. | 2015 | Details |
| A19916 | 26269698 | Case Rep Gastroenterol | Glycogenic Hepatopathy: Thinking Outside the Box. | 2015 | Details |
| A19917 | 26269440 | Zhonghua Nei Ke Za Zhi | [The impact of non-alcoholic fatty liver disease on islet function in type 2 diabetes]. | 2015 | Details |
| A19918 | 26269425 | Sci Rep | Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort. | 2015 | Details |
| A19921 | 26264980 | J Endocrinol | Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity. | 2015 | Details |
| A19925 | 26262841 | J Agric Food Chem | Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development. | 2015 | Details |
| A19926 | 26261693 | World J Hepatol | Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. | 2015 | Details |
| A19928 | 26260755 | Gut Liver | Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population. | 2016 | Details |
| A19940 | 26252921 | J Pediatr Gastroenterol Nutr | Physical Activity Is Prospectively Associated With Adolescent Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19947 | 26250514 | Obesity (Silver Spring) | Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. | 2015 | Details |
| A19949 | 26246326 | J Nutr | Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. | 2015 | Details |
| A19950 | 26246323 | J Nutr | Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats. | 2015 | Details |
| A19951 | 26244718 | J Investig Med | Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology. | 2015 | Details |
| A19954 | 26242295 | Trials | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. | 2015 | Details |
| A19955 | 26242257 | Curr Med Chem | Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy. | 2015 | Details |
| A19956 | 26242131 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [The New Idea about Early Intervention for Type 2 Diabetes Based on Gan Disease Transferring to Pi in Metabolic Diseases]. | 2015 | Details |
| A19966 | 26235878 | Biochem Biophys Res Commun | The role of endoplasmic reticulum stress and insulin resistance in the occurrence of goose fatty liver. | 2015 | Details |
| A19968 | 26234526 | Br J Nutr | The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. | 2015 | Details |
| A19973 | 26232233 | Am J Physiol Heart Circ Physiol | Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. | 2015 | Details |
| A19978 | 26228676 | J Clin Lipidol | Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. | 2015 | Details |
| A19981 | 26228038 | Lipids Health Dis | Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. | 2015 | Details |
| A19982 | 26226139 | PLoS One | Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial. | 2015 | Details |
| A19987 | 26224399 | Expert Rev Gastroenterol Hepatol | Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. | 2015 | Details |
| A19988 | 26223319 | Free Radic Res | Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. | 2015 | Details |
| A19997 | 26215532 | Am J Gastroenterol | Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. | 2015 | Details |
| A19999 | 26215323 | BMC Gastroenterol | Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. | 2015 | Details |
| A20000 | 26215259 | Nat Rev Endocrinol | Physiological and pathophysiological roles of NAMPT and NAD metabolism. | 2015 | Details |
| A20002 | 26215060 | Turk J Gastroenterol | Increased plasma CgA levels associated with nonalcoholic fatty liver disease. | 2015 | Details |
| A20004 | 26214582 | Lab Invest | Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. | 2015 | Details |
| A20006 | 26212089 | J Gastroenterol Hepatol | Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A20007 | 26211668 | Endocr J | A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease. | 2015 | Details |
| A20016 | 26203576 | Rev Med Chil | [Second Consensus of the Chilean Society of Endocrinology and Diabetes about insulin resistance]. | 2015 | Details |
| A20017 | 26203166 | J Endocrinol | Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21. | 2015 | Details |
| A20018 | 26202818 | Aliment Pharmacol Ther | Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study. | 2015 | Details |
| A20019 | 26202539 | Br J Nutr | Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study. | 2015 | Details |
| A20022 | 26201937 | Clin Endocrinol (Oxf) | Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat. | 2015 | Details |
| A20023 | 26201461 | Drugs | Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. | 2015 | Details |
| A20028 | 26200028 | Rev Esp Quimioter | Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. | 2015 | Details |
| A20032 | 26198953 | Nan Fang Yi Ke Da Xue Xue Bao | [Association between polymorphisms in pigment epithelium-derived factor gene promoter region and non-alcoholic fatty liver disease in type 2 diabetes mellitus]. | 2015 | Details |
| A20033 | 26198758 | Hepatol Int | Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20034 | 26198708 | Wiley Interdiscip Rev RNA | 'Micro-managers' of hepatic lipid metabolism and NAFLD. | 2015 | Details |
| A20035 | 26197341 | Biomolecules | Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20043 | 26193757 | Int J Urol | Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review. | 2015 | Details |
| A20050 | 26190559 | Food Funct | Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. | 2015 | Details |
| A20054 | 26189985 | Clin Res Hepatol Gastroenterol | Synergy between NAFLD and AFLD and potential biomarkers. | 2015 | Details |
| A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
| A20062 | 26185381 | World J Gastroenterol | Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. | 2015 | Details |
| A20063 | 26185377 | World J Gastroenterol | Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. | 2015 | Details |
| A20073 | 26174847 | Sleep Breath | Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. | 2015 | Details |
| A20083 | 26168700 | J Nutr Biochem | Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. | 2015 | Details |
| A20090 | 26166101 | Medicine (Baltimore) | Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2015 | Details |